Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_1
3
27%
Ph not_applicable
2
18%
Ph phase_4
1
9%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Terminated2
Recruiting1
Withdrawn1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (50.0%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

completed545%
recruiting19%
withdrawn19%
active_not_recruiting19%
unknown19%
terminated218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11